Kainos’s (KNOS) shares were on the rise on news that the IT group enjoyed its eighth consecutive year of revenue and adjusted pre-tax profit growth, with the latter rising 7 per cent to £15.2m. It was also a period of continued diversification away from the company’s core markets; international revenues climbed 18 per cent to £20.2m, while commercial revenue – as opposed to governmental – was up 19 per cent to £29.1m.
Diversity aside, sales orders were the star metric within these results, jumping a whopping 38 per cent to £131m, buoyed by better software-as-a-service bookings. In turn, this meant that Kainos’s backlog – the value of contracted revenue yet to be recognised – shot up 45 per cent to £76.4m, laying the foundations for future growth.
By business area, digital services saw revenue growth of 22 per cent to £78.6m. Here, the digital transformation segment works with central government departments including the Home Office and the Cabinet Office. Reassuringly, for now, bosses have not identified any Brexit-related repercussions for such programmes. Moreover, the group has also prioritised its commercial customer base; this expanded from 42 to 47.
Elsewhere in digital services, Kainos maintained its position as a leading Workday partner – signing 39 new clients against just 12 a year earlier. Workday provides cloud-based systems for human resources and financial management, and has become increasingly focused on the UK public sector.
The group’s smaller business, digital platforms, comprises three separate products – Smart Automated Testing, Evolve Electronic Medical Record and Evolve Integrated Care. The division saw relatively meagre revenue growth of 4 per cent to £15.9m. Both Evolve products faced NHS funding difficulties during the year, but – implying some improvement in the wider market – their combined sales orders rose from £7.8m to £10m. And the pipeline for Evolve IC looks strong, despite its progress in the US hitting a stumbling block when InTouchHealth cancelled its contract. The group must now accelerate talks with other US-based partners.
Broker Investec forecasts pre-tax profits of £17.4m and EPS of 11.6p for the year to March 2019, against £14.2m and 9.7p for FY2018.
KAINOS (KNOS) | ||||
ORD PRICE: | 402p | MARKET VALUE: | £476m | |
TOUCH: | 392-405p | 12-MONTH HIGH: | 409p | LOW: 217p |
DIVIDEND YIELD: | 1.6% | PE RATIO: | 40 | |
NET ASSET VALUE: | 30p | NET CASH: | £29m |
Year to 31 Mar | Turnover (£m) | Pre-tax profit (£m) | Earnings per share (p) | Dividend per share (p) |
2014 | 41.9 | 7.1 | na | na |
2015 | 60.8 | 11.8 | 8.9 | na |
2016 | 76.6 | 14.3 | 10.7 | 6.0 |
2017 | 83.5 | 13.3 | 8.9 | 6.3 |
2018 | 96.7 | 14.3 | 10.0 | 6.6 |
% change | +16 | +7 | +12 | +5 |
Ex-div: | 20 Sep | |||
Payment: | 19 Oct | |||
*Kainos listed its shares in July 2015 |